Three Leading Animal Health Companies Join Hands to Launch World-Class Vaccine Joint Venture Targeting Foot-and-Mouth Disease in China
Shaanxi Meili Omni-Honesty Animal Health Co., Ltd., China’s world-class vaccine company targeting foot-and-mouth disease in swine, was launched on March 24th with a groundbreaking ceremony held at the Airport New City in Xi’an, capital city of Shaanxi Province. Meili Omni-Honesty is a joint venture between Boehringer Ingelheim, a leading global pharmaceutical company and the world’s second-largest animal health company, Beijing KangMu Omni-Honesty Animal Health Products Co., Ltd. (KMOH), and China Agricultural Vet. Bio. Science and Technology Co., Ltd.(ZNWT). The total investment amounts to 840 million yuan (around €108 million). The venture will focus on research, development and manufacture of vaccines against foot-and-mouth disease on a site that will answer the latest BSL3+ biosafety standards. Production is expected to start in 2021. (The venture is subject to regulatory approval.)
“China plays a key role in Boehringer Ingelheim’s global business. With the establishment of Meili Omni-Honesty, we will bring world-class vaccine technology to China and join hands with our partners to foster local R&D and production so as to serve the Chinese market. It again demonstrates our commitment of being ‘in China, for China’,” shared Hubertus von Baumbach, Chairman of the Board of Managing Directors at Boehringer Ingelheim. “Over a thousand years ago, the ancient Silk Road connected Xi’an to Lyon. Today, Lyon, where Boehringer Ingelheim’s R&D hub for state-of-the-art technology in vaccines against foot-and-mouth disease is located, and Xi’an are connected again in the Meili Omni-Honesty project” According to Hubertus von Baumbach, Boehringer Ingelheim, as a global leader in animal health, hopes to help facilitate the growth of China’s animal health industry and develop its talents. The company is committed to contributing to the country’s animal health and food safety sectors.
In January 2017, with the acquisition of Merial, Boehringer Ingelheim further strengthened its position as a global leader in animal health. The three companies involved in the Meili Omni-Honesty project all bring unique expertise to help fight foot-and-mouth disease in China. Boehringer Ingelheim is the world’s leader in Veterinary Public Health, with state-of-the-art technology for vaccines against foot-and-mouth disease. ZNWT is approved by the Ministry of Agriculture to produce the full set of vaccines against foot-and-mouth disease. KMOH has extensive market channels across the country, as well as rich marketing experience.
Foot-and-mouth disease is a highly infectious disease that currently threatens and hinders the development of the Chinese livestock industry. It poses a big threat to the health of cloven-hoofed animals such as pigs, cattle and sheep. China National Foot and Mouth Disease Reference Laboratory under Lanzhou Veterinary Research Institute is the authorized agency to identify and confirm foot-and-mouth disease. Lanzhou Veterinary Research Institute is also an authorized research institute in China to develop vaccines against foot-and-mouth virus.
“ZNWT is relying on Lanzhou Veterinary Research Institute for technical support and is playing a leading role in prevention and control of animal diseases in China,” said Zhang Yunde, Chairman and General Manager of ZNWT. He concluded that the collaboration with Boehringer Ingelheim and KMOH will lead to unprecedented advance and breakthrough in disease prevention and control, vaccine technology and market growth. The new joint venture will tap into advantages and cooperation of the three companies to shape the swine vaccine market for foot-and-mouth disease in China.
“Foot-and-mouth disease in swine is an epidemic that has a significant impact on animal husbandry and food safety. It is highly contagious and has a high mortality rate. The market is in urgent need of vaccines featuring the world’s top-level technology,” said Yuan Ximin, Chairman of Shaanxi Meili Omni-Honesty Animal Health Co., Ltd. “I believe this project will drive transformation and upgrading of China’s animal vaccine industry, and it will also help improve economic benefits for Chinese farmers.” Yuan also shared that the Airport New City in Xi’an was chosen for the Meili Omni-Honesty project because of its policy and location advantages. The Shaanxi Pilot Free Trade Zone was formally approved in 2017, bringing new opportunities for the Airport New City. This is the only free trade zone approved in northwest China, and the core area to lead Xi’an growth. The Meili Omni-Honesty project will promote development of the bio-pharmaceutical industry chain at the Airport New City and attract more healthcare players to settle there.
Please click on the link for ‘Notes to Editors’ and ‘References’: https://www.boehringer-ingelheim.com/press-release/joint-venture-targeting-foot-and-mouth-disease-china
Media Contact - Animal Health
+49 6132 – 77 2356
Fax: +49 6132 – 77 6601
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Loxam Announces a Conditional Agreement to Acquire UK Platforms20.7.2018 14:51 | Pressemelding
Loxam Group (“Loxam”) announces that its wholly-owned subsidiary Nationwide Platforms Limited (“Nationwide”) has entered into a conditional agreement with HSS Hire Group plc (“HSS”) with respect to the acquisition of UK Platforms Limited (“UKP”). UKP specializes in renting powered access equipment from its 12 branches located throughout the United Kingdom. The company has approximately 130 employees and operates a fleet of 3,000 units. UKP is controlled by HSS since 2013. As part of this transaction, Nationwide has entered into a commercial agreement with HSS to provide powered access equipment to complement HSS’ existing fleet. The closing of the transaction is subject to the approval by HSS’ shareholders and the confirmation that it will not be referred to the Competition and Mergers Authority. The transaction is expected to close before year end 2018. Don Kenny, CEO of Loxam’s Powered Access Division states: “I am delighted with the acquisition of UKP which will further reinforce NW
Schlumberger Announces Second-Quarter 2018 Results20.7.2018 11:00 | Pressemelding
Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2018 Mar. 31, 2018 Jun. 30, 2017 Sequential Year-on-year Revenue $8,303 $7,829 $7,462 6% 11% Pretax operating income $1,094 $974 $950 12% 15% Pretax operating margin 13.2% 12.4% 12.7% 75 bps 45 bps Net income - GAAP basis $430 $525 $(74) -18% n/m Net income, excluding charges & credits* $594 $525 $488 13% 22% Diluted EPS - GAAP basis $0.31 $0.38 $(0.05) -18% n/m Diluted EPS, excluding charges & credits* $0.43 $0.38 $0.35 13% 23% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. n/m = not meaningful Schlumberger Chairman and CEO Paal Kibsgaard commented, “The second quarter was both busy and exciting for Schlumberger as we completed a number of major milestones in preparation for the broad-based global activity upturn that is now emerging. We delivered solid top-line gro
H.I.G. Capital Announces the Sale of KidsFoundation19.7.2018 19:50 | Pressemelding
H.I.G. Capital (“H.I.G.”), a leading global private equity investment firm with more than €21 billion of equity capital under management, announced today that one of its affiliates has entered a definitive agreement to sell the KidsFoundation Group (“KidsFoundation”), the Dutch market leader in childcare services, to Onex Corporation (“Onex”)(TSX:ONEX). Terms were not disclosed. Headquartered in Almere, the Netherlands, KidsFoundation provides high-quality childcare to nearly 30,000 children between the ages of six weeks and 12 years. H.I.G. created KidsFoundation in 2014 through the acquisition of assets from the estate of Estro Group. During H.I.G.’s ownership, the company has developed strongly with significant capital invested by H.I.G. to create a high-quality childcare offering. H.I.G. worked with KidsFoundation management to optimise the footprint of the company by exiting loss-making locations, introduce new IT systems to drive operational improvement and develop an internal M&
SIG Combibloc Group Holdings S.à r.l.: 2018 Second Quarter Results19.7.2018 16:01 | Pressemelding
We are pleased to announce our quarterly conference call to discuss the results of SIG Combibloc Group Holdings S.à r.l. for the second quarter ended June 30, 2018. Date: Monday, July 23, 2018 Time: 15.00 CEST / 14.00 BST / 9.00 EDT The call information will be distributed on our secure site. If you would like access to our call, please contact firstname.lastname@example.org . Regards, SIG Combibloc Group Holdings S.à r.l. View source version on businesswire.com: https://www.businesswire.com/news/home/20180719005634/en/ Contact information SIG Combibloc Group Holdings S.à r.l. Jennifer Gough email@example.com
NEORIS Announces Creation of Innovation Labs Worldwide to Create a Smarter Future19.7.2018 15:32 | Pressemelding
NEORIS, a global digital consulting services company, announced today it is consolidating the most innovative solutions it has developed in different geographies and allocating unprecedented resources to deploy a network of Innovation Labs worldwide. The main objective is to lay the foundation for the continuous development of disruptive solutions for its four core industries: Manufacturing, Financial Services, Healthcare and Telecommunications. Due to its disruptive nature, NEORIS decided that its first Innovation Lab should be housed in the Monterrey Digital Hub, which today is the first-of-its-kind as it is a space where entrepreneurs, companies, universities and investors converge to foster an ecosystem for Digital Transformation. The lab inaugurated in Monterrey, Mexico is the first of a series of Innovation Labs that will open in the different countries that NEORIS operates, and is a space where customers can experience emerging technologies through real-life scenarios. One such
CORRECTING and REPLACING Albar Capital Deploys FlexNOW19.7.2018 15:29 | Pressemelding
Subhead of release should read: Out-of-the-Box Multi-Asset Execution Management System (instead of Easy-to-Install Multi-Asset Execution Management System). The corrected release reads: ALBAR CAPITAL DEPLOYS FLEXNOW Out-of-the-Box Multi-Asset Execution Management System FlexTrade (@FlexTrade) today announced that Albar Capital Ltd., a new hedge fund led by Javier Velazquez (formerly of Millennium Capital Partners LLP), is now trading equities and futures using FlexNOW, FlexTrade’s new execution management system. “The FlexNOW team was instrumental in solving several of our problems,” said Jason Ruder, Trader at Albar Capital. “Not only are they helping us with our compliance requirements, they are also responsive to requests that improve my workflow.” According to Rhyd Lewis, FlexNOW Product Manager, FlexNOW’s quick onboarding and easy installation process was critical for Albar Capital’s launch on 2 July. “We had no problem integrating FlexNOW with Albar’s portfolio and risk managemen